Hudson Valley Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,816
Closed -$677K 169
2019
Q3
$677K Sell
6,816
-510
-7% -$48.5K 0.16% 102
2019
Q2
$677K Sell
7,326
-2,040
-22% -$194K 0.16% 104
2019
Q1
$884K Sell
9,366
-6,393
-41% -$559K 0.21% 89
2018
Q4
$1.01M Sell
15,759
-6,139
-28% -$453K 0.23% 89
2018
Q3
$1.96M Sell
21,898
-5
-0% -$442 0.45% 63
2018
Q2
$1.74M Sell
21,903
-6,755
-24% -$561K 0.43% 67
2018
Q1
$2.56M Buy
28,658
+999
+4% +$95.9K 0.64% 52
2017
Q4
$2.89M Buy
27,659
+4,088
+17% +$461K 0.71% 47
2017
Q3
$3.44M Buy
23,571
+710
+3% +$96.7K 0.89% 40
2017
Q2
$2.97M Buy
22,861
+2,185
+11% +$268K 0.82% 44
2017
Q1
$2.57M Buy
20,676
+3,030
+17% +$363K 0.72% 48
2016
Q4
$2.04M Buy
17,646
+3,138
+22% +$349K 0.6% 52
2016
Q3
$1.52M Buy
14,508
+2,586
+22% +$280K 0.47% 63
2016
Q2
$1.18M Buy
11,922
+2,002
+20% +$207K 0.38% 72
2016
Q1
$993K Buy
9,920
+1,795
+22% +$185K 0.32% 78
2015
Q4
$973K Buy
8,125
+1,150
+16% +$133K 0.3% 78
2015
Q3
$754K Buy
6,975
+1,225
+21% +$152K 0.24% 84
2015
Q2
$665K Buy
+5,750
New +$657K 0.21% 88

Other funds holding CELG

Hudson Valley Investment Advisors's CELG Position: Q4 2019 in Review

Hudson Valley Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,816 shares — an estimated $677K sold.

Hudson Valley Investment Advisors first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $3.44M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hudson Valley Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hudson Valley Investment Advisors sold 6,816 Celgene Corp shares in Q4 2019, an estimated $677K.
  • Hudson Valley Investment Advisors first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • Hudson Valley Investment Advisors's Celgene Corp position peaked at $3.44M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hudson Valley Investment Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.